Inhibition of IDO1 improved efficacy of IR in CT26 and MC38 colorectal cancer models and was associated with an increased ratio of CD8+ T cells to immunosuppressive regulatory T cells [105]. The gene discussed is CD8A; the disease is colorectal cancer.